Chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with stable COPD diagnosis; 2. Aged 40 to 80 years; 3. Patients with qi deficiency syndrome (lung qi deficiency, lung spleen deficiency, lung and kidney qi deficiency); 4. The number of acute exacerbations in the previous year >= 1; 5. Not participating in clinical studies of other interventions within 1 month before enrollment; 6. Able to tolerate lung-warming and solid-element umbilical moxibustion therapy; 7. Voluntarily accept the treatment and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. Confused, dementia, various mentally ill patients; 3. Combined with severe cardiac insufficiency; 4. Patients with active pulmonary tuberculosis, diffuse panbronchiolitis, pneumothorax, pleural effusion, and pulmonary embolism; 5. Combined with neuromuscular diseases affecting respiratory and motor function; 6. Combined tumor; 7. Severe liver and kidney disease (ALT/AST>=3 times normal value, glomerular filtration rate GFR<=29); 8. Those who are known to be allergic to the composition of moxibustion powder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and severity of chronic obstructive pulmonary disease acute exacerbations; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Evaluation of skin sensitization;Effectiveness satisfaction questionnaire;Clinical symptoms and signs;6 minutes walking distance;Dyspnea classification;Lung function;Patient Reported Outcome; | — |
Countries
China
Contacts
The First Affiliated Hospital of Henan University of Chinese Medicine